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Neuro Developmental Disorders (NDDs) are associated with signiﬁcant morbidity. This involves early 
identiﬁcation of the disorder, the correct management of the disorder and associated disabilities. In 
India, the paucity of trained personnel and lack of knowledge about these disorders has been 
instrumental in inadequate management and recognition of these NDDs. The Child Neurology 
Division, Department of Pediatrics at All India Institute of Medical Sciences has made few noteworthy 
and meaningful contributions in these aspects: devising a DM curriculum for pediatric neurology, 
developing indigenous tools for diagnosing these NDDs and performing relevant research. These 
endeavors would go a long way in serving the children with NDDs.
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ABSTRACT
Introduction
 Neuro Developmental Disorders (NDDs) 
constitute a signiﬁcant proportion of morbidity 
handled by pediatric health care services. These 
include cerebral palsy, autism, attention deﬁcit 
hyperactivity disorder (ADHD) and intellectual 
disability, epilepsy, autoimmune disorders 
including autoimmune encephalitis and 
neuromuscular disorders (including muscular 
dystrophy). A recent study estimated prevalence 
of 'any NDD' in 2–9 year old children in India to 
be 12·0% (95% CI: 10·9–13·2%), and 21·8% of 
these had more than one NDD (unpublished 
data). Thus, neurological disorders represent a 
signiﬁcant cause of morbidity among children. 
In addition, there has been a paucity of 
physicians trained in pediatric neurology and 
also, inadequate research focusing on disorders 
speciﬁc to our nation, which has further 
compromised care of these children. Hence, to 
overcome these lacunas, the Child Neurology 
Division, All India Institute of Medical Sciences 
has taken enormous steps over the past several 
years. These have been highlighted in 
subsequent sections.
DM Pediatric Neurology
 In order to overcome the scarcity of 
physicians trained in Pediatric Neurology in our 
country, Pediatric Neurology program was 
initiated in 2004, at All India Institute of Medical 
Sciences, under the Child Neurology Division as 
a part of Department of Pediatrics.  Over the past 
12 years, twenty-ﬁve residents have qualiﬁed as 
DM Pediatric Neurology.  These residents are 
subjected to rigorous training under all aspects 
of clinical care as well as neuroradiology, 
neuropathology and other clinical and 
rehabilitative aspects of child neurology.  The 
DM program at AIIMS has contributed to trained 
manpower not only in our country, but has also 
trained fellows from other SAARC nations, 
United States of America, France, and United 
Kingdom. 
Research
 There has been scarcity of research in 
pediatric neurological disorders from our 
country. Numerous national and international 
research projects have been undertaken at the 
Child Neurology Division, AIIMS, which 
contributed to the arena of epilepsy, autism, 
other  NDD (l ike cerebral  palsy) ,  and 
autoimmune disorders. The division has been a 
pioneer in the country in developing dietary 
therapies for drug resistant epilepsy (1) .  The 
children whose epilepsy fails to be adequately 
controlled despite two antiepileptic drugs are 
deﬁned to have drug resistant epilepsy (2) .  The 
therapeutic options for these children include 
epilepsy surgery or dietary therapy. The division 
has demonstrated the efﬁcacy of these dietary 
therapies in drug resistant epilepsies using 
ketogenic diet, modiﬁed Atkins diet, and low 
glycemic index dietary therapy (3-7). In 
addition, it has contributed to the development 
of 2.5:1 ketogenic diet and proved its efﬁcacy in 
institutional research (3) .  The division also, has 
been the frontrunner in diagnosing, managing 
and optimizing the treatment for autoimmune 
encephalitis (8) , leukodystrophies (9) , and 
acquired demyelinating disorders of CNS (10) . 
Also, the research focusing on domiciliary 
management  of  int ranasal  and buccal 
midazolam has helped to standardize the 
management protocols for seizures at home (11). 
These researches have been instrumental in 
developing various therapeutic guidelines, and 
have also paved the way for various national 
programs including Rashtriya Bal Swasthya 
Karyakram (RBSK) (12). 
Public Health Initiatives
 Educating the parents and children and the 
society at large is an important aspect about 
management of any disease. The Child 
Neurology Division has played a pivotal role in 
educating the society about NDDs (Fig. 1), 
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Fig. 2 : The building of AIIMS, New Delhi 
being lit blue on 30 Apr 2015 to 
commemorate Autism Day.
Fig. 1: Neurodevelopmental Disorders 
workshop was organized in December 2014. 
The picture shows the different events 
during the workshop.
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autism (Fig. 2 to 4), and epilepsy by organizing 
regular public health lectures, television and 
radio shows/ interviews, newspaper interviews 
and information materials. In addition, the 
division has published patient educational 
booklets  on al l  the common pediatr ic 
neurological disorders. These are freely 
d o w n l o a d a b l e  f r o m 
http://www.aiims.edu/en/2014-12-24-07-16-
28/neurology_educatio.html (Fig. 3) (13).  Also 
the division has launched a helpline (with mobile 
n u m b e r  9 8 6 8 3 9 9 0 3 7  a n d  e m a i l : 
a u t i s m h e l p . p e d s a i i m s @ g m a i l . c o m , 
pedneuroaiims@yahoo.com) to facilitate help to 
parents of sick children.
Assisting Government Initiatives 
 The division was part of the INCLEN 
Collaborative study (with me being the Network 
Coordinator and Site PI), which estimated the 
prevalence of various neurological disorders 
ac ross  the  coun t ry  (14-17) .  Th i s  was 
instrumental in developing the convergence 
framework of RBSK (12). Also, the division has 
worked in close liaison with the Government of 
India for the certiﬁcation of autism as a disability 
and issue of certiﬁcate for this disorder. The 
division in close collaboration with Ministry of 
Social Justice & Empowerment, Government of 
India, organized the workshop for training the 
master trainers for diagnosis of autism across the 
country in August- September 2016. This was 
aimed at formulating a uniform instrument for 
diagnosis of autism, and training health care 
professionals to use that tool and spreading 
awareness about the certiﬁcation process. 
Innovation
 The division has been signiﬁcantly 
contributed to several decisive innovations. 
These include use of skin biopsy to diagnose 
muscular dystrophy (especially collagen 6 
related disorders) (18-20). Also, the division has 
revolutionized telephonic follow-up for 
disorders like neurocysticercosis, Lennox-
Gastaut Syndrome, and Duchenne Muscular 
Dystrophy. 
 The division has also been pivotal in 
developmental of tools for diagnosis of various 
NDDs. Initially these tools were developed in 
collaboration with INCLEN (14-17).  The tools 
Fig. 3 : Autism-related patient information booklets launched 
by Child Neurology Division, Department of Pediatrics, AIIMS
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were later updated as per the latest guidelines. 
These AIIMS modiﬁed INDT tools for diagnosis 
of epilepsy, neuromuscular impairment, ADHD, 
and autism have been validated in institutional 
research. The tools for Autism Spectrum 
D i s o r d e r  ( h t t p s : / / p l a y. g o o g l e . c o m / 
store/apps/details?id=app.autism.sanyakhurana
.diagnostictoolforautismspectrumdisorder and 
https:// i tunes.apple.com/us/app/autism-
s p e c t r u m - d i s o r d e r - d i a g n o s t i c / 
i d 11 5 1 5 2 4 6 9 7 ? m t = 8 )  a n d  e p i l e p s y 
(https://play.google.com/store/apps/details?id=
com.weboutsourcing.childhoodepilepsy.childh
oodepi lepsydiagnost ic tool&hl=en and 
https://itunes.apple.com/in/app/childhood-
epilepsy-diagnostic/id1078173463?mt=8) have 
been converted into a mobile application (Fig. 4) 
which is downloadable free of cost, while 
applications for other tools are under 
development.
Microsite
 The Child Neurology Division of 
Department of Pediatrics at AIIMS launched a 
m o b i l e - b a s e d  w e b s i t e 
(m.nddworkshop2014.org) on 03-December-
2014.  This microsite was renamed as                
m.pedneuroaiims.org, in Dec 2015. This 
microsite deals in NDD including ADHD, 
Autism Spectrum Disorders, Intellectual 
Disability, Epilepsy, Learning Disability, 
Neuromuscular Disorders, Cerebral Palsy, 
Speech and Language Disorders, Hearing, and 
Vision Impairment. The microsite has various 
educational materials including videos, for 
doctors for clinical applications and for parents 
for home-based intervention (Fig. 5). 
Future
 The various initiatives mentioned above 
have laid the foundation for a healthier child 
neurology environment, where we can expect 
evidence-based management of neurological 
disorders among children. To build on these 
foundations, it is planned to perform high quality 
research covering all domains of neurology in 
collaboration with international leaders.
Conclusion 
 Neurological disorders are an enormous 
burden in terms of associated disabilities. In 
association most of these disorders are chronic 
and require patience and expertise for 
management. Various measures including 
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Fig. 4 : Snapshot of mobile app on 
Autism launched by Child Neurology Division, 
Department of Pediatrics, AIIMS 
on 28 Apr 2016
Fig. 5 : Snapshot of microsite, with autism 
related information, launched by 
Child Neurology Division, 
Department of Pediatrics, AIIMS
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training physicians, research, innovations and 
public health initiatives will immensely 
contribute in improving the management of 
these children individually and also educate the 
society about the rights of these disabled 
children.
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